Amy Caryn Sherman, MD

Amy Sherman, MD is an Instructor at Harvard Medical School, an Associate Physician at Brigham and Women’s Hospital in the Division of Infectious Diseases, and a member of the Precision Vaccines Program (PVP) at Boston Children’s Hospital with a research focus in clinical and translational vaccinology and immunology.  Her clinical focus is in transplant infectious diseases.  Dr. Sherman studied medical anthropology at the University of Pennsylvania and obtained her MD from the George Washington University. She completed internal medicine residency and infectious diseases fellowship at Emory University. She has served as a clinician researcher for various clinical studies, sponsors, and research groups, including NIH (DMID, DAIDS, DAIT, VRC), Vaccine Treatment and Evaluation Unit (VTEU), HIV Vaccine Trials Network (HVTN), HIV Prevention Network (HPTN), and the Human Immunology Project Consortium (HIPC).  With the advent of the Covid-19 pandemic, Dr. Sherman has been an investigator for the NIH COVID-19 Prevention Network (CoVPN) and has been involved with Phase 1-3 clinical trials for COVID-19 vaccines, including the Moderna mRNA-1273 vaccine, Johnson and Johnson vaccine, and Sanofi vaccine.  Her research interests focus on immunologically based investigation by translational methods to identify mechanisms of the host immune response to vaccination, especially in the context of immune compromised populations.